for the Period Ended 31 July 2023
Directors report | |
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 31 July 2023
Directors
The directors shown below have held office during the whole of the period from
1 August 2022 to 31 July 2023
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
for the Period Ended
2023 | 2022 | |
---|---|---|
| £ | £ |
Distribution costs: | ( | |
Administrative expenses: | ( | ( |
Operating profit(or loss): | ( | ( |
Profit(or loss) before tax: | ( | ( |
Profit(or loss) for the financial year: | ( | ( |
As at
Notes | 2023 | 2022 | |
---|---|---|---|
| £ | £ | |
Called up share capital not paid: | | | |
Current assets | |||
Cash at bank and in hand: | | | |
Total current assets: | | | |
Creditors: amounts falling due within one year: | 3 | ( | ( |
Net current assets (liabilities): | | | |
Total assets less current liabilities: | | | |
Creditors: amounts falling due after more than one year: | 4 | ( | ( |
Total net assets (liabilities): | ( | ( | |
Capital and reserves | |||
Called up share capital: | | | |
Profit and loss account: | ( | ( | |
Total Shareholders' funds: | ( | ( |
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 July 2023
Basis of measurement and preparation
for the Period Ended 31 July 2023
2023 | 2022 | |
---|---|---|
Average number of employees during the period | | |
for the Period Ended 31 July 2023
2023 | 2022 | |
---|---|---|
£ | £ | |
Accruals and deferred income | | |
Total | | |
for the Period Ended 31 July 2023
2023 | 2022 | |
---|---|---|
£ | £ | |
Other creditors | | |
Total | | |
The company has spent its third year in existence. Overall we have been somewhat dormant but we have contributed to our first academic peer reviewed paper.Directors have contributed time at no cost and a budget from savings to establish basic functions and to pay for this.EpSMon, an app for epilepsy monitoring achieved ORCHA accreditation, which added significantly to its market value. Psychoanalytica is a partner in this product with SUDEP Action, an epilepsy charity.We are part of N-Code, a consortium of stakeholders in a grant from the ESPRC, but have received no money directly through this. A project has been taken on but funding is received by Plymouth University.
No consultation with stakeholders
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
5 July 2024
And signed on behalf of the board by:
Name: Richard Laugharne
Status: Director